Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05786131

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (-COMPLETE-NSTEMI-)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
3,390 (estimated)
Sponsor
Leipzig Heart Science gGmbH · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.

Detailed description

The complete revascularization versus culprit lesion only PCI in NSTEMI (COMPLETE-NSTEMI) trial aims to investigate whether multivessel complete PCI is superior over culprit-lesion only PCI in patients with NSTEMI and multivessel coronary artery disease.

Conditions

Interventions

TypeNameDescription
PROCEDURECulprit-lesion revascularizationPercutaneous coronary intervention of culprit-lesion
PROCEDURENon-culprit-lesion revascularizationComplete percutaneous coronary intervention of all angiographically significant non-culprit lesions

Timeline

Start date
2023-10-27
Primary completion
2027-01-31
Completion
2027-07-31
First posted
2023-03-27
Last updated
2025-01-16

Locations

58 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT05786131. Inclusion in this directory is not an endorsement.